The biosynthesis of ursocholic acid, a secondary bile acid, is closely associated with the enzymatic activities encoded by the hdh operon in Clostridium absonum. This operon includes two contiguous genes: hdhA, encoding the 7?-hydroxysteroid dehydrogenase (7?-HSDH), and hdhB, coding for the 7?-hydroxysteroid dehydrogenase (7?-HSDH). The process begins with the enzyme 7?-HSDH, which catalyzes the oxidation of cholic acid (CA) at the 7?-hydroxy position, converting it into a 7-keto intermediate. Subsequently, the 7?-HSDH reduces this keto intermediate, but in a stereoselective manner that introduces a 7?-hydroxy group, resulting in the formation of ursocholic acid. The operon appears to be co-regulated, facilitating a coordinated response to bile acids, with promoter and regulatory sequences identified upstream of hdhA and hdhB. The biosynthetic pathway mediated by this operon exemplifies a stereospecific transformation that alters the aromatic configuration of bile acids, enabling bacteria like C. absonum to produce functionally diverse secondary bile acids such as ursocholic acid, which play pivotal roles in host-microbiome interactions and possess potential therapeutic properties.
The biosynthesis of ursocholic acid, a secondary bile acid, is closely associated with the enzymatic activities encoded by the hdh operon in Clostridium absonum. This operon includes two contiguous genes: hdhA, encoding the 7?-hydroxysteroid dehydrogenase (7?-HSDH), and hdhB, coding for the 7?-hydroxysteroid dehydrogenase (7?-HSDH). The process begins with the enzyme 7?-HSDH, which catalyzes the oxidation of cholic acid (CA) at the 7?-hydroxy position, converting it into a 7-keto intermediate. Subsequently, the 7?-HSDH reduces this keto intermediate, but in a stereoselective manner that introduces a 7?-hydroxy group, resulting in the formation of ursocholic acid. The operon appears to be co-regulated, facilitating a coordinated response to bile acids, with promoter and regulatory sequences identified upstream of hdhA and hdhB. The biosynthetic pathway mediated by this operon exemplifies a stereospecific transformation that alters the aromatic configuration of bile acids, enabling bacteria like C. absonum to produce functionally diverse secondary bile acids such as ursocholic acid, which play pivotal roles in host-microbiome interactions and possess potential therapeutic properties.
The biosynthesis of ursocholic acid, a secondary bile acid, is closely associated with the enzymatic activities encoded by the hdh operon in Clostridium absonum. This operon includes two contiguous genes: hdhA, encoding the 7?-hydroxysteroid dehydrogenase (7?-HSDH), and hdhB, coding for the 7?-hydroxysteroid dehydrogenase (7?-HSDH). The process begins with the enzyme 7?-HSDH, which catalyzes the oxidation of cholic acid (CA) at the 7?-hydroxy position, converting it into a 7-keto intermediate. Subsequently, the 7?-HSDH reduces this keto intermediate, but in a stereoselective manner that introduces a 7?-hydroxy group, resulting in the formation of ursocholic acid. The operon appears to be co-regulated, facilitating a coordinated response to bile acids, with promoter and regulatory sequences identified upstream of hdhA and hdhB. The biosynthetic pathway mediated by this operon exemplifies a stereospecific transformation that alters the aromatic configuration of bile acids, enabling bacteria like C. absonum to produce functionally diverse secondary bile acids such as ursocholic acid, which play pivotal roles in host-microbiome interactions and possess potential therapeutic properties.
The biosynthesis of ursocholic acid, a secondary bile acid, is closely associated with the enzymatic activities encoded by the hdh operon in Clostridium absonum. This operon includes two contiguous genes: hdhA, encoding the 7?-hydroxysteroid dehydrogenase (7?-HSDH), and hdhB, coding for the 7?-hydroxysteroid dehydrogenase (7?-HSDH). The process begins with the enzyme 7?-HSDH, which catalyzes the oxidation of cholic acid (CA) at the 7?-hydroxy position, converting it into a 7-keto intermediate. Subsequently, the 7?-HSDH reduces this keto intermediate, but in a stereoselective manner that introduces a 7?-hydroxy group, resulting in the formation of ursocholic acid. The operon appears to be co-regulated, facilitating a coordinated response to bile acids, with promoter and regulatory sequences identified upstream of hdhA and hdhB. The biosynthetic pathway mediated by this operon exemplifies a stereospecific transformation that alters the aromatic configuration of bile acids, enabling bacteria like C. absonum to produce functionally diverse secondary bile acids such as ursocholic acid, which play pivotal roles in host-microbiome interactions and possess potential therapeutic properties.
The biosynthesis of ursocholic acid, a secondary bile acid, is closely associated with the enzymatic activities encoded by the hdh operon in Clostridium absonum. This operon includes two contiguous genes: hdhA, encoding the 7?-hydroxysteroid dehydrogenase (7?-HSDH), and hdhB, coding for the 7?-hydroxysteroid dehydrogenase (7?-HSDH). The process begins with the enzyme 7?-HSDH, which catalyzes the oxidation of cholic acid (CA) at the 7?-hydroxy position, converting it into a 7-keto intermediate. Subsequently, the 7?-HSDH reduces this keto intermediate, but in a stereoselective manner that introduces a 7?-hydroxy group, resulting in the formation of ursocholic acid. The operon appears to be co-regulated, facilitating a coordinated response to bile acids, with promoter and regulatory sequences identified upstream of hdhA and hdhB. The biosynthetic pathway mediated by this operon exemplifies a stereospecific transformation that alters the aromatic configuration of bile acids, enabling bacteria like C. absonum to produce functionally diverse secondary bile acids such as ursocholic acid, which play pivotal roles in host-microbiome interactions and possess potential therapeutic properties.
Bacteria such as Comamonas testosteroni plays a crucial role in degradation of 4-hydroxyphthalate, an environmental pollutant. 4-hydroxyphthalate is degraded by Comamonas testosterone, yielding precursors used in the benzoate degradation pathway to yield carbon and energy, which is vital for the bacteria's growth and survival. Although the precise mechanisms of 4-hydroxyphthalate uptake, potentially facilitated by MFS transporters, are not fully understood, the subsequent enzymatic breakdown within the cell yields 4-Carboxy-2-hydroxymuconate semialdehyde, an essential intermediate for the benzoate degradation pathway.
The biosynthesis of ursocholic acid, a secondary bile acid, is closely associated with the enzymatic activities encoded by the hdh operon in Clostridium absonum. This operon includes two contiguous genes: hdhA, encoding the 7?-hydroxysteroid dehydrogenase (7?-HSDH), and hdhB, coding for the 7?-hydroxysteroid dehydrogenase (7?-HSDH). The process begins with the enzyme 7?-HSDH, which catalyzes the oxidation of cholic acid (CA) at the 7?-hydroxy position, converting it into a 7-keto intermediate. Subsequently, the 7?-HSDH reduces this keto intermediate, but in a stereoselective manner that introduces a 7?-hydroxy group, resulting in the formation of ursocholic acid. The operon appears to be co-regulated, facilitating a coordinated response to bile acids, with promoter and regulatory sequences identified upstream of hdhA and hdhB. The biosynthetic pathway mediated by this operon exemplifies a stereospecific transformation that alters the aromatic configuration of bile acids, enabling bacteria like C. absonum to produce functionally diverse secondary bile acids such as ursocholic acid, which play pivotal roles in host-microbiome interactions and possess potential therapeutic properties.
The biosynthesis of ursocholic acid, a secondary bile acid, is closely associated with the enzymatic activities encoded by the hdh operon in Clostridium absonum. This operon includes two contiguous genes: hdhA, encoding the 7?-hydroxysteroid dehydrogenase (7?-HSDH), and hdhB, coding for the 7?-hydroxysteroid dehydrogenase (7?-HSDH). The process begins with the enzyme 7?-HSDH, which catalyzes the oxidation of cholic acid (CA) at the 7?-hydroxy position, converting it into a 7-keto intermediate. Subsequently, the 7?-HSDH reduces this keto intermediate, but in a stereoselective manner that introduces a 7?-hydroxy group, resulting in the formation of ursocholic acid. The operon appears to be co-regulated, facilitating a coordinated response to bile acids, with promoter and regulatory sequences identified upstream of hdhA and hdhB. The biosynthetic pathway mediated by this operon exemplifies a stereospecific transformation that alters the aromatic configuration of bile acids, enabling bacteria like C. absonum to produce functionally diverse secondary bile acids such as ursocholic acid, which play pivotal roles in host-microbiome interactions and possess potential therapeutic properties.
